Header Logo

Connection

GUILLERMO GARCIA-MANERO to Drug Tolerance

Back to Details
This is a "connection" page, showing publications GUILLERMO GARCIA-MANERO has written about Drug Tolerance.
GUILLERMO GARCIA-MANERO
Connection Strength
0.076
Drug Tolerance
  1. Phase 1 study of the histone deacetylase inhibitor vorinostat (suberoylanilide hydroxamic acid [SAHA]) in patients with advanced leukemias and myelodysplastic syndromes. Blood. 2008 Feb 01; 111(3):1060-6.
    View in: PubMed
    Score: 0.076
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.